Experimental Physiology
	

Celebrating 100 years
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiology in Press

First published online on August 16, 2005.
Experimental Physiology (2005)
DOI: 10.1113/expphysiol.2005.031385
© The Physiological Society 2005

A more recent version of this article appeared on September 1, 2005
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
90/5/673    most recent
expphysiol.2005.031385v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Nina Eikelis
Murray D Esler
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eikelis, N.
Right arrow Articles by Esler, M. D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eikelis, N.
Right arrow Articles by Esler, M. D

Received June 20, 2005
Revised July 22, 2005
Accepted after revision July 29, 2005


Neurophysiology

The Neurobiology of Human Obesity

Nina Eikelis 1 Murray D Esler 1*

1 Baker Heart Research Institute

* To whom correspondence should be addressed. E-mail: murray.esler{at}baker.edu.au.


   Abstract
Earlier ideas that sympathetic nervous system activity is low in human obesity, contributing to weight gain through absence of sympathetically mediated thermogenesis, can now be discounted. The application of sympathetic nerve recording techniques and isotope dilution methodology quantifying neurotransmitter release from sympathetic nerves has established that the sympathetic outflows to the kidneys and skeletal muscle vasculature are activated in obese humans. The cause remains unclear. The adipocyte hormone, leptin, stimulates the sympathetic nervous system in rodents, but whether this applies in humans is uncertain. Cross- sectional studies suggest a quantitative link exists between regional sympathetic nervous tone (most notably in the kidneys) and rates of leptin release, but definitive studies documenting that leptin administration activates the human sympathetic nervous system have not been done. What might be the clinical implications of these new findings? The demonstration that the suppressed sympathetic tone characterizing many experimental models of obesity does not exist in human obesity weakens the case for the use of b3-adrenergic agonists as thermogenic agents to facilitate weight loss. Although the neurogenic character of obesity- related hypertension is now established, whether antiadrenergic antihypertensive drugs are the preferred agents for blood pressure reduction has not been adequately tested. Multiple site central venous sampling, disclosing release of leptin into the internal jugular veins, led to the demonstration that the leptin gene in expressed, in addition to adipocytes, also in the brain. Brain resistance to leptin has been inferred in human obesity, given that overweight is accompanied by high plasma leptin levels. The fact that the genes for leptin and its receptors are normally expressed in the brain in human obesity, and that release of leptin from the brain is actually increased, argues against this. Brain leptin release has the potential to override the peripheral, adipocyte leptin system.

Key Words: Noradrenaline, Obesity, Sympathetic nervous system







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2005 by the The Physiological Society.